AIM ImmunoTech (AIM) Short Interest Ratio & Short Volume

Short interest is the volume of AIM ImmunoTech shares that have been sold short but have not yet been closed out or covered. As of March 14th, investors have sold 3,170,000 shares of AIM short. Learn More on AIM ImmunoTech's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AIM shares currently have a short interest ratio of 3.0. Learn More on AIM ImmunoTech's short interest ratio.

AIM ImmunoTech saw a decline in short interest during the month of March. As of March 14th, there was short interest totaling 3,170,000 shares, a decline of 3.6% from the previous total of 3,290,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to AIM ImmunoTech: Rani Therapeutics Holdings, Inc. (15.93%), Enlivex Therapeutics Ltd. (0.36%), China SXT Pharmaceuticals, Inc. (1.62%), FibroBiologics Inc. (4.92%), Eyenovia, Inc. (4.05%), Tempest Therapeutics, Inc. (11.75%), Cara Therapeutics, Inc. (1.74%), ALX Oncology Holdings Inc. (16.09%), Generation Bio Co. (4.10%), Tenax Therapeutics, Inc. (8.58%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Domino's Pizza Inc ($736.25 million), The Campbell's Company ($649.30 million), Science Applications International Co. ($285.09 million), Brookfield Infrastructure Co. ($244.13 million), Renasant Co. ($199.30 million), Dream Finders Homes, Inc. ($153.47 million), Xerox Holdings Co. ($145.39 million), First Advantage Co. ($78.80 million), Zymeworks Inc. ($66.40 million), and Kforce Inc. ($53.83 million). View all of the most shorted stocks.

Short selling AIM is an investing strategy that aims to generate trading profit from AIM ImmunoTech as its price is falling. AIM shares are trading down $0.65 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for AIM ImmunoTech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AIM, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AIM, twice per month. The most recent reporting period available is March, 14 2025.